ADMA Biologics Inc (ADMA NASDAQ) stock market data APIs
$17.4252
-0.16(-0.9%)
as of February 2, 2026
Try our APIs with
free plan!
ADMA Biologics Inc Financial Data Overview
Price chart is built with
Anychart
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Prev. Close
17.4252
Open
17.265
High
17.5226
Low
16.9571
52 wk Range
13.5-25.67
Market Cap
4 128 M
P/E Ratio
19.6591
Shares Outstanding
238 M
Revenue
489 M
EPS
0.15
Beta
0.464
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ADMA Biologics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ADMA Biologics Inc data using free add-ons & libraries
Get ADMA Biologics Inc Fundamental Data
ADMA Biologics Inc Fundamental data includes:
- Net Revenue: 489 M
- EBITDA: 175 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ADMA Biologics Inc News
New
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
Adma Biologics (ADMA) closed at $16.96 in the latest trading session, marking a +1.37% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.5%. At the same time, the...
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?
ADMA Biologics’ ADMA shares have gained 13.8% in the past three months compared with the industry’s growth of 9%. The stock has outperformed the sector and the S&P 500 in this timeframe. The reb...
High Growth US Tech Stocks To Watch In January 2026
As the U.S. market grapples with heightened geopolitical tensions and the threat of new tariffs, major indices like the Nasdaq and S&P 500 have experienced significant declines, reflecting broader mar...
Get ADMA Biologics Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
